Cargando…
Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy
The anti-melanoma differentiation-associated gene 5 (MDA-5) antibody is a marker of clinically amyopathic dermatomyositis (CADM) and rapidly progressive interstitial lung disease (ILD) with acute respiratory failure. A 35-year-old woman with cervical cancer showed Gottron's papules, severe hypo...
Autores principales: | Ichiyasu, Hidenori, Sakamoto, Yasumiko, Yoshida, Chieko, Sakamoto, Kazuhiko, Fujita, Ryosuke, Nakayama, Go, Okabayashi, Hiroko, Saeki, Sho, Okamoto, Shinichiro, Kohrogi, Hirotsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153447/ https://www.ncbi.nlm.nih.gov/pubmed/27995057 http://dx.doi.org/10.1016/j.rmcr.2016.11.015 |
Ejemplares similares
-
Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias
por: Okabayashi, Hiroko, et al.
Publicado: (2017) -
Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber
column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a
historical control study and a review of previous studies
por: Ichiyasu, Hidenori, et al.
Publicado: (2017) -
Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021) -
A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis
por: Sasaki, Oh, et al.
Publicado: (2013) -
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19
por: Katagiri, Daisuke, et al.
Publicado: (2020)